Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
凝血磷脂依赖性凝血时间延长、内源性凝血酶潜能降低以及组织因子途径抑制剂浓度升高与新诊断的多发性骨髓瘤患者发生 VTE 的风险增加相关：前瞻性 ROADMAP-MM-CAT 研究的结果
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-018-0135-y
Fotiou Despina, Sergentanis Theodoros N, Papageorgiou Loula, Stamatelopoulos Kimon, Gavriatopoulou Maria, Kastritis Efstathios, Psaltopoulou Theodora, Salta Stella, Van Dreden Patrick, Sangare Rabiatou, Larsen Annette K, Terpos Evangelos, Elalamy Ismail, Dimopoulos Meletios A, Gerotziafas Grigoris T
